Document is current
Any future updates will be listed below
-
Authors
Kim, Jaebeom https://orcid.org/0000-0002-8870-8411
Yu, Young Suk
Choi, Yehwa
Lee, Do Hui
Han, Soobin https://orcid.org/0009-0002-2194-3289
Kwon, Junhee
Noda, Taichi https://orcid.org/0000-0003-0260-7861
Ikawa, Masahito https://orcid.org/0000-0001-9859-6217
Kim, Dongha
Kim, Hyunkyung
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Kim, Keun Il https://orcid.org/0000-0002-9680-6230
Baek, Sung Hee https://orcid.org/0000-0002-0588-8243
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2017R1A3B1023387, NRF-2021R1C1C2010332, NRF-RS-2023-00207857, NRF-2021R1A2C1006680)
- License Information
-
More Information
Article History
Received: 15 February 2024
Accepted: 15 September 2024
First Online: 27 September 2024
Competing interests
: A.B. is cofounder of CASMA Therapeutics, Inc., and Advisory board member of NexGeneration Diagnostics and Avilar Therapeutics. The remaining authors declare no competing interests.
